These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 32896913)

  • 1. Concomitant LATE-NC in Alzheimer's disease is not associated with increased tau or amyloid-β pathological burden.
    McAleese KE; Walker L; Erskine D; Johnson M; Koss D; Thomas AJ; Attems J
    Neuropathol Appl Neurobiol; 2020 Dec; 46(7):722-734. PubMed ID: 32896913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TDP-43 pathology is associated with increased tau burdens and seeding.
    Tomé SO; Tsaka G; Ronisz A; Ospitalieri S; Gawor K; Gomes LA; Otto M; von Arnim CAF; Van Damme P; Van Den Bosch L; Ghebremedhin E; Laureyssen C; Sleegers K; Vandenberghe R; Rousseau F; Schymkowitz J; Thal DR
    Mol Neurodegener; 2023 Sep; 18(1):71. PubMed ID: 37777806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LATE-NC in Alzheimer's disease: Molecular aspects and synergies.
    Tomé SO; Gawor K; Thal DR
    Brain Pathol; 2024 Jul; 34(4):e13213. PubMed ID: 37793659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of deep learning to understand resilience to Alzheimer's disease pathology.
    Lee CS; Latimer CS; Henriksen JC; Blazes M; Larson EB; Crane PK; Keene CD; Lee AY
    Brain Pathol; 2021 Nov; 31(6):e12974. PubMed ID: 34009663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of Lewy bodies with limbic-predominant age-related TDP-43 encephalopathy neuropathologic changes and their role in cognition and Alzheimer's dementia in older persons.
    Agrawal S; Yu L; Nag S; Arfanakis K; Barnes LL; Bennett DA; Schneider JA
    Acta Neuropathol Commun; 2021 Sep; 9(1):156. PubMed ID: 34563269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between hippocampal microglia, AD and LATE-NC, and cognitive decline in older adults.
    Kapasi A; Yu L; Leurgans SE; Agrawal S; Boyle PA; Bennett DA; Schneider JA
    Alzheimers Dement; 2024 May; 20(5):3193-3202. PubMed ID: 38494787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease clinical variants show distinct neuroinflammatory profiles with neuropathology.
    Boon BDC; Frigerio I; de Gooijer D; Morrema THJ; Bol J; Galis-de Graaf Y; Heymans M; ; Murray ME; ; van der Lee SJ; Holstege H; van de Berg WDJ; Jonkman LE; Rozemuller AJM; Bouwman FH; Hoozemans JJM
    Neuropathol Appl Neurobiol; 2024 Oct; 50(5):e13009. PubMed ID: 39400356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granular expression of prolyl-peptidyl isomerase PIN1 is a constant and specific feature of Alzheimer's disease pathology and is independent of tau, Aβ and TDP-43 pathology.
    Dakson A; Yokota O; Esiri M; Bigio EH; Horan M; Pendleton N; Richardson A; Neary D; Snowden JS; Robinson A; Davidson YS; Mann DM
    Acta Neuropathol; 2011 May; 121(5):635-49. PubMed ID: 21243369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LATE-NC aggravates GVD-mediated necroptosis in Alzheimer's disease.
    Koper MJ; Tomé SO; Gawor K; Belet A; Van Schoor E; Schaeverbeke J; Vandenberghe R; Vandenbulcke M; Ghebremedhin E; Otto M; von Arnim CAF; Balusu S; Blaschko MB; De Strooper B; Thal DR
    Acta Neuropathol Commun; 2022 Sep; 10(1):128. PubMed ID: 36057624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic Loss, ER Stress and Neuro-Inflammation Emerge Late in the Lateral Temporal Cortex and Associate with Progressive Tau Pathology in Alzheimer's Disease.
    Buchanan H; Mackay M; Palmer K; Tothová K; Katsur M; Platt B; Koss DJ
    Mol Neurobiol; 2020 Aug; 57(8):3258-3272. PubMed ID: 32514860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct relationships of amyloid-beta and tau deposition to cerebral glucose metabolic networks in Alzheimer's disease.
    Sun X; Nie B; Zhao S; Ai L; Chen Q; Zhang T; Pan T; Wang L; Yin X; Zhang W; Shan B; Liu H; Liang S; Wang G
    Neurosci Lett; 2020 Jan; 717():134699. PubMed ID: 31874218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctive temporal profiles of detergent-soluble and -insoluble tau and Aβ species in human Alzheimer's disease.
    Koss DJ; Dubini M; Buchanan H; Hull C; Platt B
    Brain Res; 2018 Nov; 1699():121-134. PubMed ID: 30102892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical tau load is associated with white matter hyperintensities.
    McAleese KE; Firbank M; Dey M; Colloby SJ; Walker L; Johnson M; Beverley JR; Taylor JP; Thomas AJ; O'Brien JT; Attems J
    Acta Neuropathol Commun; 2015 Sep; 3():60. PubMed ID: 26419828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance and resilience to Alzheimer's disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort.
    Latimer CS; Burke BT; Liachko NF; Currey HN; Kilgore MD; Gibbons LE; Henriksen J; Darvas M; Domoto-Reilly K; Jayadev S; Grabowski TJ; Crane PK; Larson EB; Kraemer BC; Bird TD; Keene CD
    Acta Neuropathol Commun; 2019 Jun; 7(1):91. PubMed ID: 31174609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression.
    Hales CM; Dammer EB; Deng Q; Duong DM; Gearing M; Troncoso JC; Thambisetty M; Lah JJ; Shulman JM; Levey AI; Seyfried NT
    Proteomics; 2016 Dec; 16(23):3042-3053. PubMed ID: 27718298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype.
    Davidson YS; Raby S; Foulds PG; Robinson A; Thompson JC; Sikkink S; Yusuf I; Amin H; DuPlessis D; Troakes C; Al-Sarraj S; Sloan C; Esiri MM; Prasher VP; Allsop D; Neary D; Pickering-Brown SM; Snowden JS; Mann DM
    Acta Neuropathol; 2011 Dec; 122(6):703-13. PubMed ID: 21968532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of TDP-43 splicing repression occurs early in the aging population and is associated with Alzheimer's disease neuropathologic changes and cognitive decline.
    Chang K; Ling JP; Redding-Ochoa J; An Y; Li L; Dean SA; Blanchard TG; Pylyukh T; Barrett A; Irwin KE; Moghekar A; Resnick SM; Wong PC; Troncoso JC
    Acta Neuropathol; 2023 Dec; 147(1):4. PubMed ID: 38133681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TDP-43 promotes tau accumulation and selective neurotoxicity in bigenic Caenorhabditis elegans.
    Latimer CS; Stair JG; Hincks JC; Currey HN; Bird TD; Keene CD; Kraemer BC; Liachko NF
    Dis Model Mech; 2022 Apr; 15(4):. PubMed ID: 35178571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive Decline in Preclinical Alzheimer's Disease: Amyloid-Beta versus Tauopathy.
    Huber CM; Yee C; May T; Dhanala A; Mitchell CS
    J Alzheimers Dis; 2018; 61(1):265-281. PubMed ID: 29154274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.